Elon Musk’s Neuralink raised $600 million at a valuation of $9 billion, Semafor reported Tuesday, citing anonymous sources. The brain-computer interface company implanted its third chip last month into the brain of an Arizona man with ALS. The Food and Drug Administration cleared Neuralink for human clinical trials in early 2023 and in May of this year gave the company “breakthrough device designation,” which will speed its development. Competitor Precision Neuroscience also received FDA clearance for the main component of its own brain implant. Neuralink previously raised millions from Peter Thiel’s Founders Fund, Google Ventures, Valor Equity Partners and Gigafund, a Founders Fund spinoff that has also funded Musk’s Boring Company and SpaceX. Bloomberg reported in April that Neuralink was looking to bring in another $500 million at a valuation of $8.5 billion. https://www.semafor.com/a.. #Brain Journey Network #Gadgets